NCT06523803
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06523803
Title A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Zymeworks BC Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | DEU

Facility Status City State Zip Country Details
University of Southern California - Norris Comprehensive Cancer Center Los Angeles California 90089 United States Details
University of Colorado Health Sciences Center Aurora Colorado 80045 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Icahn School of Medicine at Mount Sinai (ISMMS) - The Blavatnik Family-Chelsea Medical Center New York New York 10011 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
University of Washington Seattle Washington 98195 United States Details
Universitaetsklinikum Dresden Dresden 01307 Germany Details
Seoul National University Hospital Seoul 03080 South Korea Details
Yonsei University Health System - Severance Hospital Seoul 03722 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
The Catholic University of Korea, Seoul St. Marys Hospital Seoul South Korea Details
Guys and St Thomas' NHS Foundation Trust London SE1 9RT United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
Royal Marsden Hospital Sutton SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field